Your dog was diagnosed with Perianal (Hepatoid) Adenocarcinoma. Hepatoid gland tumours are common in intact male dogs but ~90% are benign adenomas. Adenocarcinomas (malignant) are less common. Distinguished from anal sac apocrine gland adenocarcinoma — different tumour type. Testosterone-responsive (adenomas regress with castration; carcinomas do not). Compare 2 treatment options for dogs including Surgical Excision ± Castration, Palliation / Antihormonal Therapy — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Perianal (Hepatoid) Adenocarcinoma
Canine Oncology Treatment Guide
Perianal (Hepatoid) Adenocarcinoma
Epithelial
About This Cancer
Perianal (hepatoid) adenocarcinoma is a malignant tumour arising from the hepatoid glands — specialised sebaceous glands found in the skin around the anus, so named because their cells resemble liver (hepatic) cells under the microscope. It is important to distinguish this malignant tumour from the far more common benign hepatoid adenoma, which occurs predominantly in intact male dogs and often regresses with castration. Unlike the benign form, hepatoid adenocarcinoma does not regress with castration and can occur in either sex. It also differs from anal sac apocrine gland adenocarcinoma, which is a distinct tumour type arising from a different gland. The malignant form can invade locally and spread to regional lymph nodes. Treatment is primarily surgical, and prognosis depends on the tumour size, grade, and whether complete excision is achieved.
No formal staging system
Clinically staged by tumour size, histological grade, LN status, and distant metastasis
Prognostic Factors(3)
Minimum Workup(6 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.